Home - Products - Cell Cycle/DNA Damage - DNA/RNA Synthesis - Laromustine

Laromustine

CAS No. 173424-77-6

Laromustine( —— )

Catalog No. M36332 CAS No. 173424-77-6

Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	686	In Stock
10MG	938	In Stock
25MG	1444	In Stock
50MG	1841	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Laromustine
Note

Research use only, not for human use.
Brief Description

Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
Description

Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

DNA/RNA Synthesis
Recptor

DNA/RNA Synthesis
Research Area

——
Indication

——

Chemical Information

CAS Number

173424-77-6
Formula Weight

307.78
Molecular Formula

C6H14ClN3O5S2
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(NC)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Mefenidil

Mefenidil (McN-2378), a selective cerebral vasodilator, was shown to increase CBF in healthy brains without stimulating O2 uptake in a dog anesthesia model.
T2AA

T2AA is an inhibitor of proliferating cell nuclear antigen (PCNA) with IC50 of 1 μM for PCNA/PIP-box peptide interaction.
Dacarbazine

Dacarbazine(DTIC-Dome) is an antineoplastic chemotherapy drug used in the treatment of various Ys, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas.

Sign In Join Free